drugset / Trial / NCT00845923

Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia

NCT00845923 ↗

Phase 2 Completed 22 enrolled Winston Laboratories
NaSingle-groupOpen-labelTreatment

Summary

This proof of concept study is designed to evaluate the safety and efficacy of topically administered Civamide Patch for the treatment of moderate to severe daily pain associated with postherpetic neuralgia localized to the trunk, and with localized post-incisional neuropathic pain syndromes on the trunk.

Timeline

Start
2009-03
Primary completion
2009-09
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Zucapsaicin Small molecule 0.21 mg Topical